Simultaneous screening for liver fibrosis during retinal scanning shows promise as a novel pathway for detecting advanced liver disease in patients with type 2 diabetes (T2D). International guidelines ...
YKL-40 is an inflammatory biomarker linked to tumour progression in various cancers, and its levels are consistently elevated in patients with T2D, a condition linked to increased risks for multiple ...
Data will be presented on Monday, November 18th as a late breaker poster at the American Association for the Study of Liver Diseases (AASLD) The Liver Meeting® 2024 in San Diego. LEGEND achieved its ...
Reduction in cardiovascular events seen with GLP-1 RA, SGLT-2i for type 2 diabetes, metabolic dysfunction-associated steatotic liver disease. HealthDay News — For adults with type 2 diabetes (T2D) and ...
GLP-1RAs and SGL2 inhibitors were associated with lower risks for NAFLD and NASH among patients with type 2 diabetes. Newer classes of glucose-lowering agents may reduce risk for liver disease among ...
Daix (France), Long Island City (New York, United States), November 15, 2024 – Inventiva (Euronext Paris and Nasdaq: IVA), a clinical-stage biopharmaceutical company focused on the development of oral ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results